Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Lawsuit Alleges Novo Nordisk Downplayed Ozempic Gastroparesis RisksWarning label failed to mention that symptoms of nausea and vomiting could be signs of gastroparesis from Ozempic, increasing the risk of severe injury. July 24, 2024 Irvin Jackson Add Your CommentsA West Virginia man says Ozempic gastroparesis injuries experienced by himself and a growing number of other users of the popular diabetes and weight loss treatment could have avoided if the manufacturer had come clean about the fact that gastrointestinal side effects may be signs of the more severe stomach paralysis injury.Ozempic (semaglutide) has become one of the most widely used prescription medications on the market in the United States since it was introduced by Novo Nordisk for treatment of type 2 diabetes in December 2017. As a result of the benefits the drug provides promoting weight loss, it has been widely used off-label as a diet drug.The medication is part of a new class of drugs, known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), which also includes Wegovy, Mounjaro, Zepbound and Trulicity. The drugs promote weight loss by delaying gastric emptying, which in return, makes users feel fuller for extended periods.Ozempic Gastroparesis RisksAlthough the drug warning label does indicate that some users experience nausea and vomiting, Novo Nordisk failed to adequately disclose that these symptoms may be signs of gastroparesis from Ozempic, which is a much more severe injury with long-term consequences, which was not mentioned at all on the label or prescribing information.In October 2023, a study found that Ozempic triples the risk of the stomach paralysis among users when compared to users of non-injectable weight loss drugs. The research compared theย gastrointestinal side effects of Ozempicย and other injectable GLP-1 agonists like liraglutide (Victoza and Saxenda) against those experienced by users of Contrave (bupropion-naltrexone), an oral weight management medication.The findings indicated that about 1% of Ozempic users developed stomach paralysis, compared to 0.7% of liraglutide users and around 0.3% of those on Contrave. The study highlighted that injectable semaglutide and liraglutide were significantly more likely to cause stomach paralysis and bowel obstruction than Contrave.As a result of an alleged failure to warn about the severity of these side effects, Novo Nordisk now faces a rapidly growing number ofย Ozempic lawsuitsย filed throughout the federal court system, which is ultimately expected to involve tens of thousands of lawsuits that may be brought in the coming months and years, as lawyers continue to review and investigate claims.Find Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONFind Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONA complaint (PDF) filed by Gregory H. Mann on July 15, in the U.S. District Court for the Eastern District of Pennsylvania, alleges that the drugmaker Novo Nordisk intentionally played down Ozempic gastroparesis risks on the labels warning and when representing the drug to federal regulators, in order to increase profits.Mann, 61, indicates he used Ozempic from March 2021 to May 2023 on instructions from his physician. As, a result, Mann indicates that he experienced several gastrointestinal side effects,including nausea, vomiting and diarrhea, which were later diagnosed as a gastroparesis injury, the lawsuit claims.While the warning label lists some of the symptoms of gastroparesis, such as nausea and vomiting, as common adverse reactions, it fails to include these in the โWarnings and Precautionsโ section, and never warned the patient, or medical community, that these could be signs of a more serious condition.โDefendants acknowledge that gastrointestinal events are well known side effects of the GLP-1RA class of drugs,โ Mannโs lawsuit states. โHowever, Defendants have downplayed the severity of the gastrointestinal events caused by their GLP-1RAs, never, for example, warning of the risk of gastroparesis (paralyzed stomach) and its sequalae.โMann presents claims of failure to warn and strict products liability, and seeks both compensatory and punitive damages.July 2024 Ozempic Gastroparesis Lawsuit UpdateGiven common questions of fact and law raised in complaints like Mann’s, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established coordinated pretrial proceedings for all Ozempic and other GLP-1 lawsuitsย earlier this year, transferring complaints filed throughout the federal court system to U.S. District Judge Gene E. K. Pratter in the U.S. District Court for the Eastern District of Pennsylvania. However,ย Judge Pratter passed away of May 17, and the litigation was just recently reassigned to District Judge Karen S. Marston.In a pretrial order issued on July 14, Judge Marson authorized the direct filing of new Ozempic lawsuits in the federal MDL, which will avoid delays associated with transferring claims from various different federal district courts nationwide.As the litigation continues to grow, it is expected that the Court will establish a bellwether program, by working with plaintiffs and defendants to determine what Ozempic lawsuits are representative of the greater litigation, and then sending them through case-specific fact discovery before scheduling a series of early test trials, which will help the parties gauge how juries may respond to certain evidence and testimony that would be repeated in potentially hundreds of trials.Following coordinated discovery and any early bellwether cases, if the parties are unable to negotiate Ozempic gastroparesis settlements or another resolution for the litigation, Judge Marston may later remand each claim back to the U.S. District Court where it was originally filed for trial. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Diabetes, Diabetes Drugs, Gastroparesis, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Wegovy, Weight Loss Image Credit: Natalia – stock.adobe.com Find Out If You Qualify for Ozempic or Wegovy CompensationMore Ozempic, Wegovy and Mounjaro Lawsuit Stories FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026 Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks October 30, 2026 GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind October 13, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: today)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: yesterday)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: 2 days ago)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)